UCB has selected Kroger Specialty Pharmacy as one of the Network Specialty Pharmacies to dispense BIMZELX® for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Read MoreKroger Specialty Pharmacy is proud to announce it is now dispensing ALECENSA®, GAVRETO®, and ROZLYTREK® to expand our extensive list of specialty medications in Oncology.
Read MoreKroger Specialty Pharmacy is proud to announce it is now dispensing CABENUVA (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension) for treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL), on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
Read MoreKroger Specialty Infusion is proud to announce it is now dispensing Xembify®, a 20% immune globulin indicated for treatment of primary humoral immunodeficiency disease (PIDD) in patients 2 years of age and older.
Read MoreKroger Specialty Infusion is proud to announce it is now dispensing Cuvtiru, a subcutaneous treatment for patients with primary immunodeficiency (PI) in people 2 years and older.
Read More